Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 48751-48800 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05413057
An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ
N/ARecruiting
20,000 participants
Started: Jun 23, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05374005
The Impact of Excessive Dietary Sodium on Brain Health
N/ARecruiting
220 participants
Started: Jun 22, 2022 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT06302634
Cardio-Oncology Rehabilitation Care Process
N/ARecruiting
300 participants
Started: Jun 22, 2022 · Completed: Jun 22, 2027
4 conditions1 sponsor1 location
NCT05350527
Impact of Video Information Support on Preoperative Anxiety in Breast Cancer Surgery
NARecruiting
200 participants
Started: Jun 22, 2022 · Completed: Apr 1, 2026
1 condition2 sponsors4 locations
NCT05236114
GEMINI-NSCLC: NSCLC Biomarker Study
N/ARecruiting
1,200 participants
Started: Jun 22, 2022 · Completed: Jun 30, 2029
1 condition2 sponsors57 locations
NCT05858307
Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements
N/ARecruiting
300 participants
Started: Jun 22, 2022 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT04829136
Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies
NARecruiting
30 participants
Started: Jun 22, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05609786
Dissemination and Implementation of a Web-based Relationship Safety App, myPlanKenya, for Women at Risk for Intimate Partner Violence in Nairobi, Kenya
NARecruiting
400 participants
Started: Jun 22, 2022 · Completed: Oct 31, 2025
3 conditions2 sponsors1 location
NCT05797909
The PCOS Challenge Study
N/ARecruiting
15,000 participants
Started: Jun 22, 2022 · Completed: Dec 31, 2042
1 condition1 sponsor1 location
NCT05431530
Assessment of Quality of Life After Low Anterior Resection During Cytoreductive Surgery for Advanced Ovarian Cancer
N/ARecruiting
108 participants
Started: Jun 22, 2022 · Completed: May 31, 2027
3 conditions1 sponsor1 location
NCT05098704
Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk
PHASE2/PHASE3Recruiting
90 participants
Started: Jun 22, 2022 · Completed: Jun 30, 2031
2 conditions2 sponsors10 locations
NCT04174755
Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV
NARecruiting
80 participants
Started: Jun 22, 2022 · Completed: Jan 31, 2026
2 conditions3 sponsors1 location
NCT05338801
Effect of Menthol on ENDS Users' Addiction and Exposure
NARecruiting
250 participants
Started: Jun 22, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT05092984
Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA)
PHASE3Recruiting
154 participants
Started: Jun 22, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05469945
Lymphedema After Gyneco-oncologic Treatment
NARecruiting
218 participants
Started: Jun 22, 2022 · Completed: Jun 30, 2028
2 conditions3 sponsors2 locations
NCT05146336
CytOSorb TreatMent Of Critically Ill PatientS Registry
N/ARecruiting
3,000 participants
Started: Jun 22, 2022 · Completed: Sep 30, 2032
18 conditions1 sponsor28 locations
NCT05020028
Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis
PHASE2/PHASE3Recruiting
100 participants
Started: Jun 22, 2022 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT05505409
Efficacy and Safety of Pirfenidone in CTD-ILD
PHASE4Recruiting
120 participants
Started: Jun 22, 2022 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT05222828
Effects of Mepivacaine on the Neurological Sequelae of Cerebral Infarction
PHASE2Recruiting
38 participants
Started: Jun 22, 2022 · Completed: Jun 22, 2024
1 condition1 sponsor1 location
NCT05416905
Deep Brain Stimulation for Idiopathic Craniofacial Dystonia: GPi or STN
NARecruiting
110 participants
Started: Jun 22, 2022 · Completed: May 30, 2025
2 conditions9 sponsors1 location
NCT06850922
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema
PHASE1/PHASE2Recruiting
546 participants
Started: Jun 22, 2022 · Completed: Apr 30, 2027
1 condition1 sponsor73 locations
NCT06102018
Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine
N/ARecruiting
150 participants
Started: Jun 22, 2022 · Completed: Jul 1, 2024
1 condition1 sponsor1 location
NCT06040489
Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly
PHASE2/PHASE3Recruiting
100 participants
Started: Jun 22, 2022 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT05975190
Respiratory Training and Relaxation Techniques to Improve Adjuvant Radiation Therapy in DIBH in Breast Cancer
NARecruiting
108 participants
Started: Jun 22, 2022 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT05416372
Engaging Religious Leaders to Reduce Blood Pressures in Tanzanian Communities
NARecruiting
24,000 participants
Started: Jun 22, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05513820
Automatic Detection in MRI of Prostate Cancer: DAICAP
N/ARecruiting
1,250 participants
Started: Jun 21, 2022 · Completed: Dec 31, 2024
1 condition7 sponsors1 location
NCT05270499
Aveir VR Real-World Evidence Post-Approval Study
N/ARecruiting
2,100 participants
Started: Jun 21, 2022 · Completed: Feb 28, 2034
3 conditions1 sponsor1 location
NCT05197387
Association of Intrahepatic Cholestasis of Pregnancy and Chronic Placental Inflammation
N/ARecruiting
322 participants
Started: Jun 21, 2022 · Completed: Jun 22, 2025
1 condition1 sponsor11 locations
NCT05259046
The InterVitaminK Trial - Effects of Vitamin K Supplementation on Cardiovascular, Metabolic, and Bone Health
NARecruiting
450 participants
Started: Jun 21, 2022 · Completed: Dec 1, 2026
2 conditions1 sponsor1 location
NCT05357170
Microbiome Dysfunction in Surgical Intensive Care Unit Survivors
N/ARecruiting
468 participants
Started: Jun 21, 2022 · Completed: May 31, 2028
1 condition2 sponsors1 location
NCT05336877
Aveir VR Coverage With Evidence Development Post-Approval Study
N/ARecruiting
8,744 participants
Started: Jun 21, 2022 · Completed: Jan 1, 2028
3 conditions1 sponsor1 location
NCT04901351
Multi-site HPV Screening by High-throughput Sequencing in Patients With Chronic HPV-HR Infection Followed by Gynecology
NARecruiting
30 participants
Started: Jun 21, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05314491
Multigen Plus CCK and AMF TT Cones Follow Up Study
N/ARecruiting
68 participants
Started: Jun 21, 2022 · Completed: Jul 31, 2026
2 conditions1 sponsor3 locations
NCT05422222
Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age
PHASE3Recruiting
210 participants
Started: Jun 21, 2022 · Completed: Jun 30, 2030
1 condition1 sponsor38 locations
NCT05234177
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
N/ARecruiting
300 participants
Started: Jun 21, 2022 · Completed: Feb 28, 2029
1 condition1 sponsor20 locations
NCT06480994
Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support
N/ARecruiting
1,836 participants
Started: Jun 21, 2022 · Completed: Feb 28, 2027
3 conditions5 sponsors4 locations
NCT05787795
Identifying and Characterizing Preclinical MS
N/ARecruiting
1,000 participants
Started: Jun 21, 2022 · Completed: Jun 30, 2033
1 condition2 sponsors1 location
NCT05150093
Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor
NARecruiting
120 participants
Started: Jun 21, 2022 · Completed: Aug 31, 2026
4 conditions6 sponsors1 location
NCT05377424
Adenosine 2A Receptor Antagonism and AIH in ALS
PHASE1/PHASE2Recruiting
40 participants
Started: Jun 21, 2022 · Completed: May 31, 2026
1 condition2 sponsors2 locations
NCT04629053
Causes and Outcomes of Febrile Illness in Health Facilities in Rural South and Southeast Asia
N/ARecruiting
7,200 participants
Started: Jun 21, 2022 · Completed: Dec 1, 2024
1 condition6 sponsors4 locations
NCT05296070
Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
PHASE2Recruiting
50 participants
Started: Jun 21, 2022 · Completed: Jun 30, 2029
1 condition2 sponsors4 locations
NCT05773937
A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors
PHASE1Recruiting
40 participants
Started: Jun 21, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor2 locations
NCT05430399
Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer
PHASE3Recruiting
349 participants
Started: Jun 21, 2022 · Completed: Jun 1, 2027
2 conditions3 sponsors2 locations
NCT04165616
Motor rECovery witH eArly imagiNg In STroke
N/ARecruiting
120 participants
Started: Jun 21, 2022 · Completed: Apr 30, 2026
1 condition3 sponsors3 locations
NCT05810415
Use of Renin Versus Lactic Acid as Tissue Perfusion Biomarkers for Mortality Prediction in Hypotensive Critically Ill Patients
N/ARecruiting
84 participants
Started: Jun 21, 2022 · Completed: Jan 25, 2024
5 conditions1 sponsor2 locations
NCT06291259
Mpox Prospective Observational Cohort Study
N/ARecruiting
250 participants
Started: Jun 21, 2022 · Completed: Sep 30, 2024
1 condition1 sponsor3 locations
NCT05603078
A Prospective Study of Preoperative Tumor-bed Boost Followed by Oncoplastic Surgery and Adjuvant Whole Breast Radiotherapy for Early Stage Breast Cancer (BIRKIN)
NARecruiting
102 participants
Started: Jun 21, 2022 · Completed: Jul 31, 2028
1 condition1 sponsor1 location
NCT05462106
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
PHASE1/PHASE2Recruiting
140 participants
Started: Jun 21, 2022 · Completed: Jun 30, 2026
5 conditions2 sponsors19 locations
NCT05482399
STREAM Trial - Subclinical Atherosclerosis
NARecruiting
500 participants
Started: Jun 21, 2022 · Completed: Nov 30, 2026
1 condition2 sponsors1 location
NCT05436834
A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age
PHASE3Recruiting
1,860 participants
Started: Jun 21, 2022 · Completed: Oct 27, 2025
1 condition1 sponsor74 locations